Immunological therapy in urological malignancy: Novel combination strategies

At present, immunotherapy in urological malignancy is experiencing a renaissance, particularly with the emergence of a host of innovative cancer vaccines. Herein, we will review promising immunotherapeutic approaches and evaluate the data supporting their inclusion in novel combination strategies.

Saved in:
Bibliographic Details
Published inInternational journal of urology Vol. 18; no. 2; pp. 94 - 101
Main Authors Finley, David S, Pouliot, Frederic, Chin, Arnold I, Shuch, Brian, Pantuck, Alan J, Belldegrun, Arie S, Dekernion, Jean B
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.02.2011
Subjects
Cancer Vaccines
Carcinoma, Renal Cell - therapy
combination
Data processing
Humans
Immunotherapy
Kidney Neoplasms - therapy
Malignancy
prostate cancer
renal cell carcinoma
Reviews
Online AccessGet full text

Cover

More Information
Summary:At present, immunotherapy in urological malignancy is experiencing a renaissance, particularly with the emergence of a host of innovative cancer vaccines. Herein, we will review promising immunotherapeutic approaches and evaluate the data supporting their inclusion in novel combination strategies.
Bibliography:ark:/67375/WNG-Z96BMC32-C
istex:B994DC6C818AC976B63FC7F60DEAF26098C709B4
ArticleID:IJU2664
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Feature-3
ObjectType-Review-1
ISSN:0919-8172
1442-2042
DOI:10.1111/j.1442-2042.2010.02664.x